anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

202,801-202,860 of 319,975

filter-aware
03
The slide uses a minimalist design with a central geometric icon representing the company's engine concept.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Situation & ContextLoop · Golden Circle1 hit
04
The slide uses a process-oriented timeline to break down drug development into three distinct phases with associated timeframes and complexity.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Golden Circle1 hit
05
The chart combines a line graph (investment/risk profile) with a bar chart (revenue/sales) over a 21-year timeline.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Golden Circle1 hit
06
AbCellera | Investor Conference Presentation Deck | 19 slidesAbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit
07
The central diagram is a hub-and-spoke model representing 'The Engine' supported by Technology, Infrastructure, Data Science, Integration, and Experts.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit
08
AbCellera | Investor Conference Presentation Deck | 19 slidesAbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Solution & Approach1 hit
09
The slide uses a card-based layout to categorize three types of programs: Discovery, Co-Development, and Pre-Partnered.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Solution & Approach1 hit
10
Part of a series of slides defining business model segments.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & Proof1 hit
11
The slide uses a green callout box to emphasize the deal structure.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & Proof1 hit
12
AbCellera | Investor Conference Presentation Deck | 19 slidesAbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & Proof1 hit
13
The central image is a molecular model of a bispecific antibody. The layout uses a hub-and-spoke arrangement around the molecule.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & Proof1 hit
14
The slide highlights key performance indicators related to partner programs and clinical progress, accompanied by a logo grid of partners.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & Proof1 hit
15
The slide uses a three-column layout to categorize key performance indicators.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
16
The slide uses a circular arc diagram to connect the two main pillars of capital allocation to their respective sub-activities.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
17
The diagram uses a central hub-and-spoke style structure with a surrounding circular path of secondary factors.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
18
The slide uses a 'From X to Y' framing to simplify a complex scientific process.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
19
AbCellera | Investor Conference Presentation Deck | 19 slidesAbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
01
Slide 1
The slide uses Python-like code snippets to illustrate the technical nature of their drug discovery platform.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Setup1 hit
02
Includes code snippets as decorative background elements.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Setup1 hit
03
Absci | Investor Presentation Deck | 27 slidesAbsci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Setup1 hit
04
Absci | Investor Presentation Deck | 27 slidesAbsci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · SetupLoop · Golden Circle1 hit
05
The diagram illustrates the iterative, inefficient nature of conventional drug discovery (immunization/phage display) leading to suboptimal candidates.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
The slide uses a two-column bulleted list to contrast the general AI drug discovery market with Absci's specific focus on biologics.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a two-column bulleted list to contrast traditional methods with their AI-driven approach and the resulting benefits.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide features a background image of scientists at a whiteboard with technical diagrams and code snippets, reinforcing the 'drug creation' theme.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
The slide uses a metaphor of 'creating the needle' rather than 'finding it in a haystack' to describe their AI-driven drug design process.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
The slide highlights six specific parameters: Target, Affinity, Epitope, Developability, Manufacturability, and Immunogenicity.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Solution1 hit
11
The slide uses a circular process diagram to represent the flywheel effect of their platform.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Solution1 hit
12
Uses a comparison framework to contrast data availability between small molecules and biologics.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
13
The slide uses a process flow diagram to illustrate the transition from biological wet-lab data generation to AI model training.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
14
The slide uses a linear process flow to demonstrate the end-to-end nature of the platform.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
15
The diagram is a circular flywheel process showing the integration of data, wet lab validation, and AI creation.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
16
Includes code snippet in top-left and historical clinical trial approval data in top-right as context.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
17
The slide illustrates a process flow from target antigen/epitope to AI-generated antibody scaffold, followed by wet lab validation (ACE/SPR assays) to identify binders.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
18
The slide uses a four-column layout to categorize value propositions, each supported by a visual icon or diagram.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
19
Uses a timeline comparison to illustrate value proposition.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
20
The chart uses a dot-plot visualization to represent cash flow magnitude over time, categorized by development stages.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ActionLoop · Before After1 hit
21
The slide uses a table-like layout to present key company metrics as evidence of market readiness.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ActionLoop · Before After1 hit
22
Uses quotes from partner executives to establish credibility.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ActionLoop · Before After1 hit
23
The slide highlights the strategic shift towards internal asset development alongside existing partnerships, emphasizing the credibility of the team.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
24
Includes a 'Chief Morale Officer' (a dog) as a lighthearted team member.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
25
The slide uses a grid layout to display headshots and names, with a section for corporate logos on the bottom right.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
26
The slide uses a growth curve (exponential) to visualize progress over time.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
27
Absci | Investor Presentation Deck | 27 slidesAbsci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
01
Slide 1
Includes company logo, tagline, date, and ticker symbol.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
02
Aeglea BioTherapeutics | Investor Presentation Deck | 37 slidesAeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
03
The slide uses a list-based structure to categorize updates into clinical programs and corporate status.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
04
The slide uses a Gantt-style chart to represent clinical trial progress.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
05
Aeglea BioTherapeutics | Investor Presentation Deck | 37 slidesAeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
06
The slide uses a human silhouette to map clinical manifestations to specific body systems.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
Includes two testimonials from Key Opinion Leaders (KOLs) to emphasize the patient burden.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
The slide uses a pie chart to show patient segmentation by B6 responsiveness and a timeline/number line to show age of diagnosis, followed by key metrics on clinical complications.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
Includes a biological process diagram showing intracellular vs plasma metabolism.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
10
The slide outlines a multi-part clinical trial design with specific dosing cohorts and patient eligibility requirements.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
11
The chart displays efficacy data for a drug candidate, noting the impact of anti-drug antibodies (ADAs) on the third cohort.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
12
Aeglea BioTherapeutics | Investor Presentation Deck | 37 slidesAeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
13
ADA stands for Anti-Drug Antibodies.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
14
Aeglea BioTherapeutics | Investor Presentation Deck | 37 slidesAeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
15
The slide uses a timeline-based visual to show disease progression.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
16
The slide uses a two-column layout to contrast commercial/regulatory status with clinical trial outcomes.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Loop · Jobs To Be Done1 hit